Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.

We describe a 55-year-old man with acute myelogenous leukemia who developed breakthrough Trichosporon asahii fungemia during 5 days of micafungin treatment. Although the patient's clinical condition improved considerably after the start of voriconazole treatment, blood culture results remained positive for T. asahii for 3 days, and fever persisted for 7 days thereafter. The patient achieved complete hematological remission, and he received successful consolidation chemotherapy without developing Trichosporon infection with the prophylactic use of voriconazole therapy. This case report illustrates that voriconazole may be useful in the treatment of disseminated T. asahii infection in neutropenic patients.

[1]  Masami Takeuchi,et al.  Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  E. Roilides,et al.  Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. , 2005, Journal of pediatric hematology/oncology.

[3]  L. Pagano,et al.  Invasive Infections Caused by Trichosporon Species and Geotrichum capitatum in Patients with Hematological Malignancies: a Retrospective Multicenter Study from Italy and Review of the Literature , 2005, Journal of Clinical Microbiology.

[4]  J. Lipton,et al.  Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Bassetti,et al.  Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B. , 2004, The Journal of antimicrobial chemotherapy.

[6]  R. Jacobs,et al.  Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection. , 2003, The Pediatric infectious disease journal.

[7]  D. Wolf,et al.  Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole , 2003, Journal of Clinical Microbiology.

[8]  H. Dombret,et al.  Use of Voriconazole to Successfully Treat Disseminated Trichosporon asahii Infection in a Patient with Acute Myeloid Leukaemia , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[9]  K. Sepkowitz,et al.  Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Herbrecht,et al.  Chronic disseminated Trichosporon asahii infection in a leukemic child. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  J. Rex,et al.  In Vitro Antifungal Susceptibilities of Trichosporon Species , 2002, Antimicrobial Agents and Chemotherapy.

[12]  D. Wolf,et al.  Multidrug-Resistant Trichosporon asahii Infection of Nongranulocytopenic Patients in Three Intensive Care Units , 2001, Journal of Clinical Microbiology.

[13]  G. Lucarelli,et al.  Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts , 2000, Bone Marrow Transplantation.

[14]  M. Nasu,et al.  Trichosporon beigelii pneumonia in patients with hematologic malignancies. , 1995, Chest.

[15]  G. S. Hoog,et al.  Trichosporon on humans: a practical account , 1994, Mycoses.

[16]  E. Anaissie,et al.  Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  G. Lopez-Berestein,et al.  Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. , 1992, The Journal of infectious diseases.

[18]  T. Walsh,et al.  Trichosporonosis in Patients with Neoplastic Disease , 1986, Medicine.